Citation Impact
Citing Papers
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization
2020
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
2024 StandoutNobel
Factors associated with spontaneous clearance of chronic hepatitis C virus infection
2016
Mortality among British Columbians testing for hepatitis C antibody
2013
Oral diseases: a global public health challenge
2019 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis
2017
IFN‐λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection
2016
Validation of TaqMan® SNP genotyping specificity for rs12979860 of IL-28B: Modeling primer specificity in vitro
2014
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Hepatocellular carcinoma
2016 Standout
Diffusion-limited Reaction of Free Nitric Oxide with Erythrocytes
1998
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Burden of liver diseases in the world
2018 Standout
Hepatitis C: The next 25 years
2014 StandoutNobel
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C
2015
A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite
2001 Standout
Mixed HCV infection and reinfection in people who inject drugs—impact on therapy
2015
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
2015
Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition
1996
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution
1996
Clinical approaches to treatment of Internet addiction
2014 Standout
Effect of α-α Diaspirin Crosslinked Hemoglobin (DCLHbTM) on the Potency of Sodium Nitroprusside and Nitroglycerine to Decrease Blood Pressure in Rats: A Dose-Response Study
2000
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs
2015
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
2017
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
2016
Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice
2014
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe
2016
Can hepatitis C virus infection be eradicated in people who inject drugs?
2014
MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection
2017
Hepatitis C reinfection after sustained virological response
2016
Post-infectious autoimmune disorders: Sydenham’s chorea, PANDAS and beyond
2014
HCV epidemiology in high-risk groups and the risk of reinfection
2016
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
2016
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Global burden of liver disease: 2023 update
2023 Standout
Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314–324 in Complex with Antibody IGH526
2015
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Challenges and Promise of a Hepatitis C Virus Vaccine
2019
The densely fluorinated nanospace of a porous coordination polymer composed of perfluorobutyl-functionalized ligands
2014 StandoutNobel
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C
2017
Pulmonary Hypertension and Systemic Vasoconstriction May Offset the Benefits of Acellular Hemoglobin Blood Substitutes
1997
Haemoglobin-based erythrocyte transfusion substitutes
2001
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
2022
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Treatment with direct‐acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study
2017
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2affinity
1999
Enhancement of Platelet Deposition by Cross-Linked Hemoglobin in a Rat Carotid Endarterectomy Model
1996
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Bupropion in the treatment of problematic online game play in patients with major depressive disorder
2011
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some PhysiologyBlut ist ein ganz besondrer Saft
2001
Controlled Safety Study of a Hemoglobin-Based Oxygen Carrier, DCLHb, in Acute Ischemic Stroke
1999
Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?
2015
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men
2019
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
2016 StandoutNobel
Viral Metagenomics on Cerebrospinal Fluid
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
The impact of hepatitis C burden: an evidence‐based approach
2014
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Artificial Oxygen Carriers as Red Blood Cell Substitutes – Perfluorocarbons and Cell-Free Hemoglobin
2000
Combined Neuroprotection and Reperfusion Therapy for Stroke
1996
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Works of Bart Grady being referenced
Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
2013
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Children with Tourette's Syndrome May Suffer Immunoglobulin A Dysgammaglobulinemia: Preliminary Report
2009
Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance
2016
No Impact of Hepatitis C Virus Infection on Mortality Among Drug Users During the First Decade After Seroconversion
2011
Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status
2014
Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men
2015
Female Sex and IL28B, a Synergism for Spontaneous Viral Clearance in Hepatitis C Virus (HCV) Seroconverters from a Community-Based Cohort
2011
Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam
2012
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study
2015
Identification of a new genotype of Torque Teno Mini virus
2013
A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin.
1993